Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chuck Harrell

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|February 3, 2026
Therapeutic synergies that overcome carboplatin resistance in triple-negative breast cancerJulia E Altman, Aaron Valentine, Nina Dashti-Gibson, et al.
NPJ Breast Cancer|September 23, 2016
αB-crystallin Expression in Breast Cancer is Associated with Brain MetastasisK David Voduc, Torsten O Nielsen, Charles M Perou, et al.
Clinical & Experimental Metastasis|August 27, 2013
Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasisJ Chuck Harrell, Adam D Pfefferle, Nicole Zalles, et al.
Bioinformatics (Oxford, England)|March 14, 2026
Beyond Blacklists: A Critical Assessment of Exclusion Set Generation Strategies and Alternative ApproachesBrydon P G Wall, Jonathan D Ogata, My Nguyen, et al.
Breast Cancer Research : BCR|July 7, 2012
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathwaysRitsuko Iwanaga, Chu-An Wang, Douglas S Micalizzi, et al.
Breast Cancer Research and Treatment|July 24, 2012
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signaturesPeter Kabos, Jessica Finlay-Schultz, Chunling Li, et al.
Breast Cancer Research : BCR|March 2, 2019
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumoursArian Lundberg, Linda S Lindström, Jingmei Li, et al.
Journal of Lipid Research|October 14, 2018
Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancerMelissa A Maczis, Michael Maceyka, Michael R Waters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer CohortsArian Lundberg, Linda S Lindström, J Chuck Harrell, et al.
Cancer Research|October 24, 2014
Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer modelsJessica Bockhorn, Aleix Prat, Ya-Fang Chang, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Journal of Experimental & Clinical Cancer Research : CR|February 3, 2026
Therapeutic synergies that overcome carboplatin resistance in triple-negative breast cancerJulia E Altman, Aaron Valentine, Nina Dashti-Gibson, et al.
NPJ Breast Cancer|September 23, 2016
αB-crystallin Expression in Breast Cancer is Associated with Brain MetastasisK David Voduc, Torsten O Nielsen, Charles M Perou, et al.
Clinical & Experimental Metastasis|August 27, 2013
Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasisJ Chuck Harrell, Adam D Pfefferle, Nicole Zalles, et al.
Bioinformatics (Oxford, England)|March 14, 2026
Beyond Blacklists: A Critical Assessment of Exclusion Set Generation Strategies and Alternative ApproachesBrydon P G Wall, Jonathan D Ogata, My Nguyen, et al.
Breast Cancer Research : BCR|July 7, 2012
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathwaysRitsuko Iwanaga, Chu-An Wang, Douglas S Micalizzi, et al.
Breast Cancer Research and Treatment|July 24, 2012
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signaturesPeter Kabos, Jessica Finlay-Schultz, Chunling Li, et al.
Breast Cancer Research : BCR|March 2, 2019
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumoursArian Lundberg, Linda S Lindström, Jingmei Li, et al.
Journal of Lipid Research|October 14, 2018
Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancerMelissa A Maczis, Michael Maceyka, Michael R Waters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer CohortsArian Lundberg, Linda S Lindström, J Chuck Harrell, et al.
Cancer Research|October 24, 2014
Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer modelsJessica Bockhorn, Aleix Prat, Ya-Fang Chang, et al.
Pageof 8